Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Navigating the EU AI Act: Unpacking High-Risk Classification and Its Profound Implications for Enterprises
Data Science & Bioinformatics

Navigating the EU AI Act: Unpacking High-Risk Classification and Its Profound Implications for Enterprises

Evan Lee Salim Jul 19, 2026 0

The European Commission’s latest draft guidelines represent a pivotal step towards clarifying how organizations must classify high-risk artificial intelligence (AI)…

Read More
Clinical Diagnostics & Pathology

The Integration of Artificial Intelligence in Diagnostic Medicine: A Paradigm Shift with Profound Implications for Radiology and Clinical Laboratories

Reynand Amr Wu May 22, 2026 0

The healthcare landscape is on the cusp of a transformative era, driven by the rapid advancements in artificial intelligence (AI),…

Read More
Biotech & Genetic Research

The Gut-Brain Axis: Unveiling the Microbiome’s Profound Influence on Neurological Health and Disease

Jia Lissa Apr 2, 2026 0

The intricate connection between the far-flung organs of the gastrointestinal tract and the central nervous system, commonly known as the…

Read More
Bioengineered Bone Marrow-on-a-Chip Platform Revolutionizes Human Hematopoiesis Research and Drug Toxicity ScreeningPharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic FlexibilityThe enemy of your parasite is your friendThe Rise of Agentic AI Coding Platforms: Empowering a New Generation of App Developers
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ